IntrinsicIntrinsic

Other Events ·

Endovia Health Sciences amends equity line to raise ownership cap from 4.99% to 9.99%

EDVAEndovia Health Sciences, Inc.

On October 15, 2026, Endovia Health Sciences entered into a letter agreement with C/M Capital Master Fund, LP to amend its existing Securities Purchase Agreement. The amendment increases the investor's beneficial ownership limitation from 4.99% to 9.99%, effective immediately. Additionally, the parties waived notice requirements and other provisions of the original agreement that are inconsistent with this change. Endovia Health Sciences operates in the healthcare sector.

More from Endovia Health Sciences, Inc.

Explore EDVA